We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
1401
Palvella Therapeutics
PVLA
$2.08B
| $433K | ﹤0.01% |
1,749
| – | – |
|
1402
Blackstone
BX
$105B
| $431K | ﹤0.01% |
+7,613
| New | +$401K |
|
1403
Financial Institutions
FISI
$807M
| $429K | ﹤0.01% |
23,100
+2,700
| +13% | +$47.1K |
|
1404
Kodak
KODK
$780M
| $427K | ﹤0.01% |
+191,900
| New | +$446K |
|
|
DBD
1405
DELISTED
Diebold Nixdorf Incorporated
DBD
| $427K | ﹤0.01% |
70,600
+9,900
| +16% | +$48.8K |
|
1406
Gerdau
GGB
$9.44B
| $426K | ﹤0.01% |
181,440
| – | – |
|
1407
Oil-Dri
ODC
$1.44B
| $426K | ﹤0.01% |
24,600
+2,000
| +9% | +$34.6K |
|
|
VAPO
1408
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $426K | ﹤0.01% |
+1,300
| New | +$274K |
|
1409
Inovio Pharmaceuticals
INO
$79.6M
| $425K | ﹤0.01% |
+1,317
| New | +$211K |
|
|
BHVN
1410
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $424K | ﹤0.01% |
+5,800
| New | +$309K |
|
1411
Quanex
NX
$853M
| $423K | ﹤0.01% |
30,500
-6,700
| -18% | -$79.8K |
|
1412
Principal Financial Group
PFG
$24B
| $421K | ﹤0.01% |
10,157
-18,952
| -65% | -$691K |
|
1413
Designer Brands
DBI
$297M
| $417K | ﹤0.01% |
+61,600
| New | +$372K |
|
1414
Goodyear
GT
$2.04B
| $415K | ﹤0.01% |
+46,500
| New | +$353K |
|
1415
First Business Financial Services
FBIZ
$567M
| $414K | ﹤0.01% |
25,200
+2,100
| +9% | +$32.8K |
|
1416
First Bancorp
FNLC
$389M
| $414K | ﹤0.01% |
19,100
+1,600
| +9% | +$33K |
|
1417
Glacier Bancorp
GBCI
$6.43B
| $412K | ﹤0.01% |
11,700
+900
| +8% | +$33.4K |
|
|
ITIC
1418
Investors Title Co
ITIC
$537M
| $412K | ﹤0.01% |
3,400
+300
| +10% | +$37.4K |
|
1419
Newmark Group
NMRK
$2.82B
| $412K | ﹤0.01% |
84,900
+7,000
| +9% | +$29.4K |
|
1420
International Seaways
INSW
$4.47B
| $410K | ﹤0.01% |
+25,100
| New | +$546K |
|
1421
DHI Group
DHX
$170M
| $409K | ﹤0.01% |
195,000
+21,800
| +13% | +$56K |
|
1422
Shenandoah Telecom
SHEN
$631M
| $409K | ﹤0.01% |
8,300
+3,400
| +69% | +$172K |
|
1423
SouthState Bank Corp
SSB
$10.2B
| $409K | ﹤0.01% |
8,600
+6,200
| +258% | +$324K |
|
|
EFOR
1424
Everforth Inc
EFOR
$887M
| $406K | ﹤0.01% |
6,100
+3,800
| +165% | +$202K |
|
1425
Adeia
ADEA
$2.85B
| $405K | ﹤0.01% |
+103,950
| New | +$393K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.